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Abstract: 
Purpose 
The purpose of this study was to explore the meaning of insulin among a sample of Hispanic 
immigrants with type 2 diabetes and their family members/significant others. 
Method 
Forty-three Hispanics with type 2 diabetes and their family members/significant others were 
recruited in the southeastern United States for a family-based intervention study on diabetes self-
management. Focus groups were conducted in which participants with diabetes and family 
members were asked to describe their perceptions of insulin. The sessions were audiotaped and 
transcribed, translated from Spanish into English, and analyzed using standard content analysis. 
This article reports the findings as well as demographic information and hemoglobin A1C levels 
of participants. 
Results 
The meaning of insulin was described by both Hispanic immigrants with type 2 diabetes and 
their family members/significant others. Participants’ perceptions were categorized into three 
major themes: (1) negative perceptions of insulin therapy, (2) perceived barriers to insulin 
therapy, and (3) positive experiences with insulin emerged from qualitative data. 
Conclusions 
The Hispanic immigrants with diabetes and their family members/significant others in this study 
described perceptions and fears of insulin indicating a lack of understanding of the diabetes 
disease process and the progressive nature of diabetes. Strategies and further research are 
necessary to dispel negative perceptions and facilitate positive experiences with insulin for 
patients and family members/significant others. 
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Article: 
Type 2 diabetes is a progressive disease resulting in a decline in β-cell pancreatic function and a 
decrease in insulin secretion.1 Consequently, insulin therapy may be required to achieve and 
maintain glycemic control and prevent microvascular and neuropathic complications associated 
with type 2 diabetes.2 Current diabetes therapy guidelines recommend early initiation and 
intensive adjustment of insulin, in addition to oral hypoglycemic agents, to maintain a 
hemoglobin A1C (A1C) level less than 7% in adults.3,4 However, many people with diabetes are 
not effective in their self-care management and they suffer from daily symptoms and long-term 
complications.5⇓-7 This is especially true for Hispanics with diabetes; many of them do not 
achieve glycemic control8 and must be hospitalized for hyperglycemia.9 Kuo et al.10 for 
example, reported that inconsistent use of insulin was associated with an increase in diabetes-
related deaths and all-cause mortality among Mexican American seniors (N = 908) over a 7-year 
period. 
Psychological insulin resistance is the term used for refusing insulin or delaying the initiation of 
insulin therapy.11,12 Factors associated with psychological insulin resistance are poorly 
understood, though a number of studies have examined the phenomenon. A multistate study of 
1267 persons with type 2 diabetes found that commonly reported negative beliefs about insulin 
included restrictiveness of lifestyle (45.2%), permanence (once you begin insulin, you can never 
quit; 45%), fear of hypoglycemia (43.3%), personal failure (43.3%), and low self-efficacy 
(43.3%).12 In that sample, ethnic minorities were significantly less willing to use insulin than 
non-Hispanic Whites (35% vs. 22.4%; P < .01). Larkin et al.11 found similar negative attitudes 
toward insulin in a study of insulin-naive persons with type 2 diabetes who were predominantly 
non-Hispanic White. Reported negative attitudes toward insulin included fear of hypoglycemia 
(59%), permanence (56%), feelings of failure (49%), and fear of self-injection (< 40%). In 
addition, 61% reported that using insulin would worry their family or friends, and 77% believed 
that using insulin meant their diabetes was worse. 
Prior research with predominate non-Hispanic populations has shown that unwillingness to use 
insulin is common among persons with type 2 diabetes, with as many as 20% to 53% refusing 
insulin therapy despite recommendations by their health care provider11⇓⇓-14 or delaying the 
initiation of insulin therapy because of negative attitudes and fears about insulin.14 However, 
little research has been conducted on the perspectives of Hispanics in regard to insulin, and no 
research has looked at the views of family members of Hispanics with diabetes. Understanding 
the meaning of insulin as perceived by Hispanic immigrants with diabetes and their family 
members can help health providers deliver culturally competent care and overcome barriers to 
diabetes self-management. 
Study Purpose 
 
The purpose of the study therefore was to explore the meaning of insulin in a sample of Hispanic 
immigrants with type 2 diabetes and their family members/significant others living in the 
southeastern United States. 
Method 
 
Design, Sample, and Setting 
The data reported here were gathered as a part of a family-based study of diabetes self-
management intervention for mainly Mexican immigrants with type 2 diabetes. Participants were 
recruited from a community-supported clinic in central North Carolina that provides health 
services to low-income Hispanics and uses sliding scale payment. Flyers were posted in the 
clinic. The Hispanic clinic coordinator introduced the study to clients, and a bilingual and 
bicultural research team member recruited participants. Eligibility criteria included self-
identification as Hispanic, age 18 years or older, a medical diagnosis of type 2 diabetes on the 
clinic record, a family member/significant other willing to participate, and ability to speak 
Spanish or English. Participants who were pregnant or who had type 1 diabetes or cognitive 
impairment were excluded. The study was approved by the clinic director and by the Institutional 
Review Board of the University. 
Participants attended an 8-week diabetes education intervention that was culturally tailored to 
Hispanics with type 2 diabetes and their family members/significant others. The study also 
included three focus group sessions with the Hispanics with type 2 diabetes and family members 
or significant others. Focus groups were chosen because they offer an efficient and reliable 
design for exploratory research questions.15 Specifically, the focus groups allowed the 
participants to express their perceptions, beliefs, and attitudes toward insulin in relations to 
diabetes self-management. A total of 43 Hispanics with type 2 diabetes (n = 21) and their family 
members/significant others (n = 22) participated in the focus groups. This article reports the 
focus group findings. 
Data Collection and Analysis 
 
Each focus group consisted of 10 to 16 participants. A structured interview guide that included 
one open-ended question exploring perceptions of insulin was used. Morgan15 suggests 
questions flow from very general to more specific. The focus group interviews began by asking 
“Please tell us what you think about insulin.” Two follow-up questions were “What worries you 
about insulin?” and “What has been your experience with insulin?” The focus groups were 
facilitated in Spanish by the second author, a bilingual family nurse practitioner with training in 
qualitative research methods, who has worked with the Hispanic community for more than 25 
years, and a bicultural and bilingual native Spanish interpreter. Each session lasted 20 to 30 
minutes. The focus group discussions were audiotaped and transcribed verbatim in Spanish. The 
Spanish transcriptions were then translated into English by a bicultural and bilingual research 
team member. To assure accuracy, all Spanish transcriptions were checked against the 
audiotapes by two bilingual research assistants. Finally, each English translation was reviewed 
and verified by two bilingual persons for congruence. 
The focus group transcripts were analyzed utilizing the strategies described by Morgan15 for 
qualitative data analysis. After first reading through each transcript, significant text segments 
pertaining to perceptions and barriers of insulin use were identified. Word codes were then 
assigned to each text segment. The codes were examined by the research team for discrepancies 
in interpretation, and significance and discrepancies were discussed until consensus on 
interpretation was achieved. Similar codes were clustered to categories and then assigned into 
major themes. A qualitative expert reviewed and confirmed the findings for the final level of data 
analysis. Credibility was met by allowing focus group participants to fully share their 
experiences and by using bilingual and bicultural interviewers.16 Sharing transcripts and reading 
consensus on data interpretation established the confirmability of study findings. 
Results 
Characteristics of Participants 
The average age of participants was 47 (SD = 12.31) years. The average age of those with 
diabetes was 51 (SD = 9.95) years, and the average for family members/significant others was 42 
years (SD = 12.98). The majority of participants were female (72.1%). The average hemoglobin 
A1C for participants with diabetes was 8.56% (SD = 2.42), and for family members/significant 
others it was 6.35% (SD = 1.87). More than half of the participants with type 2 diabetes took oral 
hypoglycemic agents (68.4 %), and a third (31.6%) used insulin injections. All participants were 
immigrants; most were from Mexico (83.3%). The average length of time living in the United 
States was 15.5 years (SD = 7.68). Demographic information is presented in Table 1. 
Table 1 has been omitted form this formatted document. 
Perceptions of insulin were identified in the focus group interviews with Hispanic immigrants 
with type 2 diabetes and their family members/significant others. The data were analyzed, coded, 
and categorized into themes derived from participants’ discussions and responses to the open-
ended questions. These perceptions were categorized into three major themes: (1) negative 
perceptions of insulin therapy, (2) perceived barriers to insulin treatment, and (3) positive 
experiences with insulin. 
Negative Perceptions of Insulin Therapy 
Both participants with diabetes and their family members/significant others expressed negative 
perceptions of insulin therapy and fear that using insulin would result in organ damage and even 
death. The negative perceptions about insulin included the idea that insulin kills, insulin scares, 
insulin is the last resort possible, and insulin itself causes problems and damages the body. 
Insulin kills 
Participants linked the use of insulin to impending death. Some voiced the belief that insulin kills 
people with diabetes: 
There was a lady with diabetes and she would inject herself with insulin and she died. My 
mom who has diabetes would take a pill that she would put in water in order to take it. So 
far, my mom has lived many happy years. (Female, age 49) 
Because of a lack of information in my family, we thought that when you inject insulin in 
your body, it is as if you are already dead. It kills you. (Female, age 40) 
Insulin scares 
Participants expressed fears about insulin therapy and described insulin treatment as scary and 
associated with advanced diabetes: 
Well, what I’ve heard about insulin is that when you have to use insulin it means that 
your diabetes is very advanced and that you also can lose your sight. (Female, age 68) 
I have heard people say that using insulin is the worst thing possible. I tell you this 
because in Mexico, when I talk with my mom, she says that my sister-in-law became 
diabetic while pregnant. A year later she now has diabetes permanently. She doesn’t take 
care of herself. Now, they tell me that I should take care of myself. My mom says that my 
sister-in-law is in a bad way and she must give herself insulin injections . . . I tell my 
mom that my sister-in-law is not going to last much longer. And it scares me because the 
doctor says that he might have to switch me over to insulin. (Female, age 35) 
Insulin is a “last resort.” 
Several participants believed that using insulin injections was the worst treatment to be used for 
diabetes and should only be used as a last resort: 
A lot of people think that using insulin is the last resort. It is the worst. I think that many 
people think like this. (Female, age 34) 
Insulin causes problems and damages 
Many participants described perceptions that insulin caused health problems and damaged their 
bodies. For example, some participants associated insulin with increased hunger and being 
forced to inject themselves. Other persons believed that insulin resulted in blindness and renal 
failure. 
I have used insulin for four years. I feel like the insulin makes me eat a lot and makes me 
very hungry. I feel like it doesn’t help me because at times it affects my appetite and then 
I eat more. (Female, age 52) 
I think that insulin is a big problem because you have to stick yourself and stick yourself. 
(Female, age 35) 
From using insulin you get swollen. It damages your kidneys and your blood changes 
every three days. I have a neighbor in Mexico who is going blind. (Female, age 46) 
They say that insulin cures some areas, but affects other areas as insulin supposedly is 
controlling sugar. But it damages the kidneys also. That is what the doctor told me. It 
heals the one and affects the other. (Male, age 47) 
Perceived Barriers to Insulin Therapy 
The second major theme was perceived barriers to insulin therapy. Perceived barriers to insulin 
therapy reported by participants include insulin inconvenience and a lack of family support for 
using insulin. 
Insulin is inconvenient 
Many participants identified inconvenience as a barrier to using insulin therapy. Participants who 
had used insulin experienced difficulties when they were away from home because they needed 
to carry a cooler. Also, they reported difficulties in accessing syringes for insulin therapy: 
The problem is when someone goes out, you always have to take a cooler. (Female, age 
40) 
Before, I was never able to get the syringes, because here they won’t sell you the syringes 
because you can use them for bad things, like drugs. (Female, age 40) 
One participant thought that insulin pens were easier to use, therefore more convenient: 
Those insulin things that look like pencils that they have now, so that you do not have to 
have syringes. With those things like pencils you can give yourself a shot. You just push 
down like you would on a pencil. My niece has those and only uses the pencils. However, 
you still need a cooler. (Female, age 40) 
Lack of family support for using insulin 
A lack of family support and knowledge was also identified as a barrier to insulin therapy. 
Family members’ misconceptions about the disease process sometimes influenced participants 
with diabetes not to use insulin because the families did not see the effectiveness of insulin 
therapy. One family member said: 
I saw my mom thin, starving. . . . When she [her mom who had diabetes] asks questions 
about using insulin, I would tell her “don’t take it,” “don’t take it,” because my mom 
does not drink sodas, does not drink juices, does not eat bread, no chili, nothing, not rice, 
not tortillas, but the disease continues. (Female, age 40) 
Positive Experiences With Insulin 
The final theme was positive experiences with insulin. Despite negative perceptions of insulin 
and barriers to insulin therapy, a few participants reported positive experiences with insulin 
treatment. They indicated that insulin made them feel better and they perceived insulin as more 
helpful than oral hypoglycemic agents: 
I have used insulin for five years. I don’t feel bad. I inject myself every day. (Female, age 
58) 
From what I have seen and heard, I think that insulin is better than pills. (Female, age 42) 
I felt very bad before insulin. But since I started using insulin I feel well because I’ve had 
diabetes for seven years and I have never gone to a hospital. (Female, age 32) 
Discussion 
We explored the meanings of insulin of both the individual and family levels among Hispanics 
with diabetes and their family members. Participants reported negative perceptions about insulin 
therapy, perceived barriers to insulin therapy, and positive experiences with insulin. These 
negative perceptions and barriers to insulin use can be major challenges to successful diabetes 
self-management. Although some of the negative perceptions and perceived barriers to insulin 
identified in this study have been previously described in the literature among non-Hispanic 
populations,11⇓⇓-14,17 the study findings provide unique perspectives on insulin from both 
individual and family that extended beyond fear and negative attitudes toward insulin treatment. 
Thus, family support and family members’ understanding of diabetes, diabetes management, and 
cultural beliefs about insulin need to be included in diabetes education for Hispanics with 
diabetes. 
Negative perceptions about insulin in the current study with predominantly Mexican immigrants 
might be related to the fear that the start of insulin therapy could be a sign of advanced stage of 
disease or impending death. These negative perceptions and fears may be related to prior 
practices of initiating insulin late in the treatment plan, which was more common before the 
development and use of long-acting insulin analogs.18 Cultural beliefs that insulin is toxic and 
patients’ and families’ perceptions that insulin is associated with diabetes complications may 
contribute to refusal of insulin therapy.19 Lack of knowledge about insulin and its side effects 
was reported to be associated with fears of insulin.20 Knowledge deficits in diabetes and its 
associated risk factors have also been found among Hispanic populations.21 Many Hispanics 
may lack knowledge on the pen device for the administration of insulin due to the fact that they 
may not be able to access the health care system, receive education of this delivery system, or 
afford this treatment option. This was particularly common in this sample and may have been 
due to the fact that many Hispanic immigrants in the United States are socially and economically 
disadvantaged, have limited access to health care services, and have cultural and language 
barriers.22 Findings of the study are consistent with a previous research showing that many 
Hispanic patients with diabetes have negative perceptions of insulin23 and many patients with 
diabetes delay or refuse to use insulin. This lack of adherence to the treatment of diabetes is 
primarily related to hassles related to insulin, uncertainty about self-administration of insulin, or 
fears of their disease having progressed into a serious stage.22,24 Caballero and colleagues,25 
for example, reported that 43% of Hispanics with diabetes believed that insulin can cause 
blindness. Jezewski and Poss26 reported that Mexican Americans expressed fear of using insulin 
thought insulin might lead to addiction and cause blindness and they believe an association 
between insulin use and serious stage of the diabetes. 
Participants in this study also said that inconvenience, inaccessibility of syringes, and a lack of 
family support are major barriers to insulin therapy. A previous study reported that most patients 
with diabetes worried about the inconvenience of insulin and its consequences resulting in 
restrictiveness of lifestyle.27 Accessing syringes was a great concern, perhaps because of low 
income and lack of health insurance. Also, all participants were immigrants, and difficulties in 
accessing syringes may have been related to their lack of familiarity with the health care system 
of the United States. These findings are consistent with reports by Campos28 that socioeconomic 
factors, language and health literacy issues, cultural issues, and patient-provider relationship are 
barriers to the successful use of insulin in Hispanics with type 2 diabetes. 
Another major barrier to insulin therapy was a lack of family support. Participants reported that 
family members discouraged the use of insulin because of their misconceptions about the disease 
process. Cultural concepts of maintaining family support and cohesiveness as well as smooth 
social relationships are important factors in diabetes self-management in Hispanic culture.29,30 
Other researchers have noted that family support and religious faith are key facilitators of 
diabetes self-management among Hispanic patients.31 While in Hispanic cultures there is a high 
expectation of receiving support from family members or friends, with decreased family size and 
increased responsibilities outside the home, family members may not be available to provide 
support to the individual who has diabetes.32 A recent study of Hispanics with diabetes reported 
that participants with diabetes perceived they received less support from their children because 
the children were busy. Also, family members provided them with high-fat and high-calorie 
foods despite their diabetes conditions.33 Further, Mexican women with diabetes have reported a 
lack of general family support.34 Several studies have suggested that diabetes education for 
Hispanic populations be provided within a family context.35,36 Also, promoting and facilitating 
family support can be significant in overcoming barriers to insulin therapy in this population. 
Finally, despite negative attitudes and perceptions of insulin, some of these participants reported 
positive experiences with insulin, perhaps because they received positive information about 
insulin from their health care providers. Thus, diabetes education for this population should 
include the positive effects of insulin. 
Several limitations of this study must be noted. The convenience sample of Hispanic immigrants 
with type 2 diabetes and their family members/significant others was drawn from one clinic that 
in particular serves Mexican immigrants, and they might not represent populations who live in 
other communities with large populations of Hispanics or Hispanics who have immigrated from 
Latin America areas. 
 
Implications 
 
Overcoming factors associated with psychological insulin resistance among Hispanic immigrants 
with type 2 diabetes is critical for improving their acceptance of insulin therapy and preventing 
delays in initiating or continuing this essential treatment option. The findings reported indicate 
that participants with diabetes and family members/significant others have misperceptions and 
fears of insulin, which may originate in part from a lack of diabetes knowledge of the 
comprehensive impact and progressive nature of the disease. 
Diabetes education directed for patients and family members is essential. Including family 
members in educational interventions and emphasizing the role of family in the disease process 
are important for successful adherence to a diabetes self-care regimen.37 Family members need 
to learn about diabetes, strategies to develop healthy behaviors, and psychological supports to the 
family member with diabetes. Education provided to family members should integrate cultural 
values and beliefs about diabetes, dispel their negative perceptions about insulin, and facilitate 
positive experiences. Discussing insulin therapy early in care, not as a threat or personal failure, 
but as an essential hormone necessary for achieving glycemic control and preventing 
complications, is one method to overcome psychological insulin resistance.38 Encouraging 
patients and their family members/significant others to ask questions and voice concerns about 
insulin promotes rapport and provides a basis from which to begin to negotiate treatment options. 
Incorporating family members/significant others in these discussions is an important culturally 
competent strategy when working with Hispanic patients.22 Careful consideration is needed of 
socioeconomic barriers such as lack of health insurance and affordability of glucose testing 
supplies and insulin, syringes, or pen delivery systems.39,40 Other identified considerations 
include assessment of visual acuity, manual dexterity, confidence in ability to self-inject, and 
receptiveness toward a simplified versus complex insulin regimen.22,38,39 
Primary care physicians, nurse practitioners, physician assistants, and certified diabetes 
educators must be familiar with various insulin regimens and be willing to initiate insulin early 
in the treatment plan as recommended by current guidelines and algorithms.3,4 Delaying the use 
of insulin has been reported to be significantly more common among US physicians and nurses 
than those from other countries according to a multinational investigation of more than 3700 
physicians and nurses.27 Currently, basal insulins, such as insulin detemir and insulin glargine, 
are recommended as step 2 therapy if lifestyle and the maximal tolerated dose of metformin fail 
to achieve glycemic goals.4 The addition of basal insulins may be an appropriate method for 
introducing insulin to Hispanic patients as these insulin analogs have a long duration of action, 
flat action time, usually require only once daily dosing, and have a lower incidence of 
hypoglycemia.38 
Providing quality care for Hispanics with diabetes requires cultural competence and 
interpersonal communication skills incorporating personalismo (warm, personal relationships), 
respeto (respect), and simpatía (kind, courteous interactions) in order to build trust and respect 
and promote honest dialogue and rapport between Hispanic patients, family members, and health 
care providers.22,41 Prior research findings indicate that when there is a perceived lack of these 
social amenities with health care providers, then Hispanic patients are less likely to disclose 
pertinent information, comply with treatment recommendations, and are less satisfied with the 
care they receive.42,43 Finally, non–English-speaking Hispanic patients with type 2 diabetes and 
their family members require access to appropriate and timely care as well as diabetes education 
in a language they can understand and that incorporates cultural values and beliefs that are 
meaningful and able to dispel negative perceptions of insulin. 
Hispanics with diabetes and their family members in this sample described the major negative 
perceptions related to regular and appropriate insulin usage. Diabetes education programs 
tailored for this population should include information pertaining to the negative perceptions that 
Hispanics have about insulin and diabetes. Strategies to address barriers associated with 
psychological insulin resistance at both the patient and family/significant other level, as well as 
at the health care provider level, are required to meet national health objectives to alleviate this 
health disparity. Future research exploring barriers to insulin with regards to diabetes knowledge, 
communication/language barriers, and health care provider factors that may be associated with 
Hispanic clients’ psychological insulin resistance will provide additional knowledge that can be 
translated to providers, policy, and delivery systems. 
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